These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells. Alissafi T; Hatzioannou A; Mintzas K; Barouni RM; Banos A; Sormendi S; Polyzos A; Xilouri M; Wielockx B; Gogas H; Verginis P J Clin Invest; 2018 Aug; 128(9):3840-3852. PubMed ID: 29920188 [TBL] [Abstract][Full Text] [Related]
7. Enhancement of antitumor immunity in lung cancer by targeting myeloid-derived suppressor cell pathways. Sawant A; Schafer CC; Jin TH; Zmijewski J; Tse HM; Roth J; Sun Z; Siegal GP; Thannickal VJ; Grant SC; Ponnazhagan S; Deshane JS Cancer Res; 2013 Nov; 73(22):6609-20. PubMed ID: 24085788 [TBL] [Abstract][Full Text] [Related]
8. Effective combinatorial immunotherapy for castration-resistant prostate cancer. Lu X; Horner JW; Paul E; Shang X; Troncoso P; Deng P; Jiang S; Chang Q; Spring DJ; Sharma P; Zebala JA; Maeda DY; Wang YA; DePinho RA Nature; 2017 Mar; 543(7647):728-732. PubMed ID: 28321130 [TBL] [Abstract][Full Text] [Related]
9. SMAC Mimetic Debio 1143 and Ablative Radiation Therapy Synergize to Enhance Antitumor Immunity against Lung Cancer. Tao Z; McCall NS; Wiedemann N; Vuagniaux G; Yuan Z; Lu B Clin Cancer Res; 2019 Feb; 25(3):1113-1124. PubMed ID: 30352911 [TBL] [Abstract][Full Text] [Related]
10. Tumor-infiltrating Treg, MDSC, and IDO expression associated with outcomes of neoadjuvant chemotherapy of breast cancer. Li F; Zhao Y; Wei L; Li S; Liu J Cancer Biol Ther; 2018 Aug; 19(8):695-705. PubMed ID: 29621426 [TBL] [Abstract][Full Text] [Related]
11. CXCL17-derived CD11b Hsu YL; Yen MC; Chang WA; Tsai PH; Pan YC; Liao SH; Kuo PL Breast Cancer Res; 2019 Feb; 21(1):23. PubMed ID: 30755260 [TBL] [Abstract][Full Text] [Related]
12. Obesity-Associated Myeloid-Derived Suppressor Cells Promote Apoptosis of Tumor-Infiltrating CD8 T Cells and Immunotherapy Resistance in Breast Cancer. Gibson JT; Orlandella RM; Turbitt WJ; Behring M; Manne U; Sorge RE; Norian LA Front Immunol; 2020; 11():590794. PubMed ID: 33123173 [TBL] [Abstract][Full Text] [Related]
13. Altered Metabolism in Glioblastoma: Myeloid-Derived Suppressor Cell (MDSC) Fitness and Tumor-Infiltrating Lymphocyte (TIL) Dysfunction. Di Ianni N; Musio S; Pellegatta S Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33923299 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies. Hossain F; Al-Khami AA; Wyczechowska D; Hernandez C; Zheng L; Reiss K; Valle LD; Trillo-Tinoco J; Maj T; Zou W; Rodriguez PC; Ochoa AC Cancer Immunol Res; 2015 Nov; 3(11):1236-47. PubMed ID: 26025381 [TBL] [Abstract][Full Text] [Related]
15. Hirsutella sinensis Inhibits Lewis Lung Cancer via Tumor Microenvironment Effector T Cells in Mice. Fu H; Jin L; Shao X; Li Y; Chen F; Shou Z; Tang X; Ji B; Shou Q Am J Chin Med; 2018; 46(4):911-922. PubMed ID: 29754506 [TBL] [Abstract][Full Text] [Related]
16. Myeloid-derived suppressor cells-new and exciting players in lung cancer. Yang Z; Guo J; Weng L; Tang W; Jin S; Ma W J Hematol Oncol; 2020 Jan; 13(1):10. PubMed ID: 32005273 [TBL] [Abstract][Full Text] [Related]
17. Chemoresistance in mesenchymal lung cancer cells is correlated to high regulatory T cell presence in the tumor microenvironment. Zhang LN; Xin T; Chen M; Gao P IUBMB Life; 2019 Jul; 71(7):986-991. PubMed ID: 31066485 [TBL] [Abstract][Full Text] [Related]
18. The prognostic effects of tumor infiltrating regulatory T cells and myeloid derived suppressor cells assessed by multicolor flow cytometry in gastric cancer patients. Choi HS; Ha SY; Kim HM; Ahn SM; Kang MS; Kim KM; Choi MG; Lee JH; Sohn TS; Bae JM; Kim S; Kang ES Oncotarget; 2016 Feb; 7(7):7940-51. PubMed ID: 26799288 [TBL] [Abstract][Full Text] [Related]
19. Plasmodium infection inhibits the expansion and activation of MDSCs and Tregs in the tumor microenvironment in a murine Lewis lung cancer model. Adah D; Yang Y; Liu Q; Gadidasu K; Tao Z; Yu S; Dai L; Li X; Zhao S; Qin L; Qin L; Chen X Cell Commun Signal; 2019 Apr; 17(1):32. PubMed ID: 30979375 [TBL] [Abstract][Full Text] [Related]
20. Determination of poor prognostic immune features of tumour microenvironment in non-smoking patients with lung adenocarcinoma. Kinoshita T; Kudo-Saito C; Muramatsu R; Fujita T; Saito M; Nagumo H; Sakurai T; Noji S; Takahata E; Yaguchi T; Tsukamoto N; Hayashi Y; Kaseda K; Kamiyama I; Ohtsuka T; Tomizawa K; Shimoji M; Mitsudomi T; Asamura H; Kawakami Y Eur J Cancer; 2017 Nov; 86():15-27. PubMed ID: 28950145 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]